Hims & Hers Health stock support test: Support levels in focus

Traders Union
All News
Stocks
Hims & Hers Health slides 0.45% today

Highlights

The Federal Trade Commission, Utah, and Los Angeles County filed a complaint against Hims & Hers Health for alleged failures in disclosure and data handling.
Multiple class action lawsuits have been filed against Hims & Hers Health, increasing legal risk and raising reputational concerns.
Shares of Hims & Hers Health trade below key moving averages, with bearish momentum and a 2 to 3 day projected range of $26.74 to $29.04.

Legal actions intensify risk as investor sentiment turns cautious

The main news affecting HIMS centers on regulatory and legal developments, as noted by Prnewswire, Financialcontent, and Globenewswire. On July 29, 2026, the Federal Trade Commission, the State of Utah, and Los Angeles County filed a federal complaint against Hims & Hers Health, alleging failures in disclosing prescription billing practices, complicated subscription cancellations, and improper sharing of consumer health data with third-party advertisers. The complaint has triggered multiple class action lawsuits, leading to increased legal risk and potential reputational concerns for the company. These developments have heightened investor caution and contributed to a more uncertain outlook.

Technical selling pressure dominates as momentum signals remain bearish

Technically, HIMS is trading below the MA-20 and MA-50 on the hourly chart as well as the MA-200 on the daily timeframe, reflecting pressure across short, medium, and long-term horizons. The Ichimoku Kijun level at $28.47 stands as immediate resistance. Momentum indicators remain negative: MACD signals a sell, ADX is neutral, while RSI, Stoch RSI, and CCI all show bearish conditions. Bull/Bear Power confirms prevailing seller dominance, and recent intraday volatility aligns with these bearish momentum signals.

Sideways trade expected as volatility contains near-term downside risk

Over the next 2–3 trading days, HIMS is likely to trade within a volatility band from $26.74 to $29.04, with low probability of a rebound and high likelihood of further downside. The most probable scenario is sideways movement within this range. A bullish signal would require a clear break above resistance at $28.47, while a decisive move below $26.74 would validate a renewed bearish scenario.

Anton Kharitonov, expert at Traders Union, sees heightened downside risk for Hims & Hers Health after regulatory and legal setbacks. He notes that the stock remains under pressure technically, with a negative tone reinforced by bearish momentum signals and the recent wave of class action lawsuits. With price stuck below key moving averages and resistance levels, the outlook stays cautious in the short term. "Until HIMS clears resistance at $28.47 and resolves its legal issues, I remain defensive and do not trust any rebound attempts."

Earlier, analysts noted that ongoing legal issues and mixed technical signals were leading to a period of uncertainty and consolidation for Hims & Hers Health shares. The current analysis strengthens this view by highlighting persistent downside risk and recommends monitoring the $28.47 resistance area for any sign of a short-term reversal.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.